KALA BIO Establishes $15M At-The-Market Offering, Signaling Significant Potential Dilution

summarizeSummary

KALA BIO, Inc. has initiated an At-The-Market offering to sell up to $15 million in common stock, a move that could provide necessary capital but also result in substantial dilution for shareholders.

check_boxKey Events

• New At-The-Market Offering

  KALA BIO, Inc. has established an At-The-Market (ATM) offering agreement with H.C. Wainwright & Co., LLC.

• Up to $15 Million in Stock Sales

  The company is authorized to sell up to $15 million of its common stock from time to time through the ATM program.

• Potential Share Dilution

  This offering mechanism allows for the gradual sale of shares, which could lead to significant dilution for current shareholders and create an overhang on the stock price.

• Sales Agent Commission

  H.C. Wainwright & Co., LLC will receive a 3.0% commission on the gross sales price of shares sold under the agreement.

auto_awesomeAnalysis

KALA BIO, Inc. has entered into an At-The-Market (ATM) offering agreement to sell up to $15 million of its common stock. This substantial capital raise, while providing potential funding, introduces significant potential dilution for existing shareholders as shares will be sold into the market over time. The company will pay a 3.0% commission on gross sales.